Imiquimod (Taro Pharmaceuticals U.S.A., Inc.)
Welcome to the PulseAid listing for the Imiquimod drug offered from Taro Pharmaceuticals U.S.A., Inc.. This Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Taro Pharmaceuticals U.S.A., Inc. |
| NON-PROPRIETARY NAME: | Imiquimod |
| SUBSTANCE NAME: | IMIQUIMOD |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2011-04-15 |
| END MARKETING DATE: | 0000-00-00 |
Imiquimod HUMAN PRESCRIPTION DRUG Details:
| Item Description | Imiquimod from Taro Pharmaceuticals U.S.A., Inc. |
| LABELER NAME: | Taro Pharmaceuticals U.S.A., Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/g) |
| START MARKETING DATE: | 2011-04-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51672-4145_cd5069f0-4bdf-46cf-8278-cc821732f5c8 |
| PRODUCT NDC: | 51672-4145 |
| APPLICATION NUMBER: | ANDA200173 |
Other IMIQUIMOD Pharmaceutical Manufacturers / Labelers:
